---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/266233487.md"
description: "Johnson & Johnson's stock price has reached a historic high, with the latest increase of 1.9%; the company plans to acquire Halda for $3.05 billion to expand its cancer business footprint"
datetime: "2025-11-17T15:51:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/266233487.md)
  - [en](https://longbridge.com/en/news/266233487.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/266233487.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/266233487.md) | [繁體中文](https://longbridge.com/zh-HK/news/266233487.md)


# 

Johnson & Johnson's stock price has reached a historic high, with the latest increase of 1.9%; the company plans to acquire Halda for $3.05 billion to expand its cancer business footprint

### Related Stocks

- [Johnson & Johnson (JNJ.US)](https://longbridge.com/en/quote/JNJ.US.md)

## Related News & Research

- [J&J’s Darzalex nets first self-administered cancer injectable approval](https://longbridge.com/en/news/280822205.md)
- [Daratumumab becomes first oncology injectable approved for patient administration](https://longbridge.com/en/news/280990101.md)
- [HCG Extends Timeline for Additional 34% Stake Purchase in Vizag Cancer Hospital](https://longbridge.com/en/news/280910854.md)
- [Cardinal Health Boosts Actinium-225 Production Capacity to Meet Demand for Novel Cancer Therapies](https://longbridge.com/en/news/281360890.md)
- [Orser Capital Management LLC Purchases Shares of 5,217 Johnson & Johnson $JNJ](https://longbridge.com/en/news/280872064.md)